Trimoxi is a compounded, preservative-free triamcinolone acetonide [steroid] and moxifloxacin [antibiotic] delivered during cataract surgery after the cataract (cloudy lens) is removed and after the new intraocular lens is placed.
Studies at Kaiser Permanente in Northern California have shown that thousands of cataract surgeries performed with this “dropless” technique have been proven safe and less risk for infection. Our surgeons believe it is so important that we at The Harman Eye Clinic absorb the cost of the medication. This means less expense for our patients, (often saving our patients hundreds of dollars), less inconvenience of needing to apply eyedrops several times a day for a month or more, and less side effects such as irritation, blur, topical allergy. Although uncommon, some glaucoma patients may develop a “steroid response” where the eye pressure becomes elevated due to the presence of steroid (triamcinolone) in the “dropless” formula. Most patients experience a temporary blur and black spots in their vision from the medication which is usually gone within a few days.
Less than 10% of patients may develop “rebound inflammation”, usually after a couple of weeks post-operatively, and may require the addition of topical steroid and/or non-steroidal drops. Some patients are not candidates for the “dropless” technique, such as those with a history of prior vitrectomy surgery, allergy to fluoroquinolone antibiotics, or advanced glaucoma.
Our patients and co-managing physicians have been pleased with the effectiveness and convenience of “dropless” cataract surgery!
Download our latest, comprehensive Patient’s Guide to Successful Cataract Surgery, or request an appointment for a cataract evaluation and your surgeon will be able to address your questions on an individual manner after your eyes have been examined with an overall evaluation of your health, life-style and vision potential. Call The Harman Eye Clinic in Arlington today, the first step to life without cataracts.